Interviews and Profiles
-
Sofie Pattijn, Co-Founder and Chief Technology Officer, ImmunXperts, Belgium
- Assay Development
- Immuno-Oncology Drug Development
-
Drs. Mindy and Amy Engevik, Assistant Professors, Medical University of South Carolina (MUSC), and Dr. Kristen Engevik, Postdoctoral Associate, Baylor College of Medicine.
- William Housley, PhD
William Housley, Ph.D., Postdoctoral Fellow, Yale School of Medicine
- Genetic basis of autoimmune diseases
- Human immunology
- Dr. Bas Trietsch
Bas Trietsch, PhD, Chief Technology Officer, MIMETAS
Disease Modeling, Drug Discovery and Toxicity Testing, Epithelial Cell Biology, Organoids, Stem Cell Biology - Kyle Burrows, BSc
Defining Mechanisms Controlling Mucosal Inflammation: T Cells and ILCs
- Role and regulation of Th17 cells in mucosal sites
- Analysis and role of Innate Lymphoid Cells (ILCs) in mucosal immunity
- Ramin Herati, MD
Ramin Herati, MD, Infectious Disease Fellow, University of Pennsylvania
- Circulating T follicular helper cells in infectious diseases
- Vaccinations in the elderly
- Scott Allen, PhD
Scott Allen, Ph.D., Senior Non-Clinical Fellow, the University of Sheffield
Neuroscience, Stem Cell Biology -
Daniel Gray, Ph.D., Laboratory Head, Walter and Eliza Hall Institute
Stem Cell Biology - Andreia Costa, BSc
Andreia Costa, Ph.D. Candidate, Fred Hutchinson Cancer Research Center
- Role of Tregs in neurotropic infections
- Treg-eliciting vaccines